海外の治験の状況「%E8%84%B3%E5%8D%92%E4%B8%AD」での検索結果
33件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 国名
- 登録日
Recruiting
- A Study to Evaluate the Long-term Safety and Tolerability of Lu AF20513 and the Antibody Response in Patients With Alzheimer's Disease (AD)
- Alzheimer's Disease
- Austria, Finland, Sweden
- 2018-09-11
Recruiting
- Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
- Atopic Dermatitis;Atopic Dermatitis;Atopic Dermatitis;Atopic Dermatitis
- Australia, Austria, Belgium, Bulgaria, Canada, China, Czech Republic, Denmark, Estonia, Finland, France, Germany, Hungary, Italy, Japan, Korea, Republic of, Lithuania, Netherlands, New Zealand, Poland, Romania, Russian Federation, Singapore, Slovakia, Spain, United Kingdom, United States
- 2013-09-20
Recruiting
- A Study to Evaluate Upadacitinib in Adolescent and Adult Subjects With Moderate to Severe Atopic Dermatitis
- Atopic Dermatitis
- Australia, Austria, Belgium, Bulgaria, Canada, Croatia, Czechia, Denmark, France, Germany, Greece, Hungary, Ireland, Italy, Korea, Republic of, Netherlands, New Zealand, Portugal, Singapore, Spain, Taiwan, United Kingdom, United States
- 2018-07-25
Recruiting
- A Study of Baricitinib (LY3009104) in Children and Adolescents With Atopic Dermatitis
- Atopic Dermatitis
- Argentina, Australia, Austria, Brazil, Czechia, France, Germany, Hungary, Israel, Mexico, Poland, Russian Federation, Spain, Switzerland, Taiwan, United Kingdom
- 2019-05-15
Recruiting
- A trial of BEvACizumab added to temozolomide +/- irinOtecan for children with refractory/relapsed Neuroblastoma
- Neuroblastoma in children aged =1 to =21 years Cancer Malignant neoplasm of adrenal gland
- Austria, Belgium, Denmark, France, Germany, Ireland, Italy, Netherlands, Spain, Switzerland, United Kingdom
- 2013-04-24
Recruiting
- A Study of Baricitinib (LY3009104) in Combination With Topical Corticosteroids in Adults With Moderate to Severe Atopic Dermatitis
- Atopic Dermatitis
- Argentina, Australia, Austria, Germany, Italy, Japan, Korea, Republic of, Poland, Spain, Taiwan
- 2018-10-30
Recruiting
- A Study to Evaluate Upadacitinib in Combination With Topical Corticosteroids in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis
- Atopic Dermatitis
- Australia, Austria, Belgium, Canada, China, Czechia, France, Germany, Greece, Hong Kong, Hungary, Ireland, Israel, Italy, Japan, Netherlands, New Zealand, Norway, Puerto Rico, Slovakia, Spain, Sweden, United Kingdom, United States
- 2018-06-14
Recruiting
- A Long-term Study of Baricitinib (LY3009104) With Topical Corticosteroids in Adults With Moderate to Severe Atopic Dermatitis That Are Not Controlled With Cyclosporine or for Those Who Cannot Take Oral Cyclosporine Because it is Not Medically Advisable
- Atopic Dermatitis
- Austria, Belgium, Brazil, Finland, France, Germany, Italy, Japan, Netherlands, Poland, Russian Federation, Spain, Switzerland, United Kingdom
- 2018-02-05
Recruiting
- Evaluation of Upadacitinib in Adolescent and Adult Patients With Moderate to Severe Atopic Dermatitis (Eczema)- Measure Up 1
- Atopic Dermatitis
- Argentina, Australia, Bosnia and Herzegovina, Bulgaria, Canada, China, Colombia, Croatia, Denmark, Estonia, Finland, France, Germany, Italy, Japan, Malaysia, New Zealand, Puerto Rico, Romania, Russian Federation, Switzerland, Turkey, Ukraine, United Kingdom, United States
- 2018-06-14
Recruiting
- A Phase III Case Series Clinical Study of the Reversal of the Anticoagulant Effects of Dabigatran by Intravenous Administration of 5.0g Idarucizumab (BI 655075) in Patients Treated Wtih Dabigatran Etexilate Who Have Uncontrolled Bleeding or Require Emergency Surgery or Procedures.RE-VERSE AD (A Study of the RE-VERSal Effects of Idarucizumab on Active Dabigatran) Trial
- Hemorrhage;D68.3 - Haemorrhagic disorder due to circulating anticoagulants
- Argentina, Australia, Austria, Belgium, Canada, Chile, Colombia, Czech Republic, Denmark, Estonia, Finland, France, Germany, Hong Kong, Ireland, Israel, Italy, Korea, Republic of, Latvia, Mexico, Netherlands, New Zealand, Norway, Poland, Portugal, Russian Federation, Singapore, Slovakia, South Africa, Spain, Sweden, Taiwan, Province of China, United Kingdom, United States
- 2015-07-22